SCHEMBL7537525

SCHEMBL7537525

Nc1ncc(CCCC(=O)O)[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.46
▸ TBXAS1 P24557 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HDAC3 O15379 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23824708 0.89 AOC3 (0.49) AOC3HSD17B10
SCHEMBL8225111 0.79 AOC3 (0.50) AOC3ALDH1A1MAPTHSD17B10
SCHEMBL12598153 0.75 AOC3 (0.48) AOC3
SCHEMBL12598154 0.73 HRH3 (0.50) AOC3
SCHEMBL12598535 0.73 CASP2 (0.49) ALDH1A1MAPTHSD17B10
SCHEMBL18071081 0.72 GRIA1 (0.46) AOC3ALDH1A1
SCHEMBL14114477 0.72 AOC3 (0.46) AOC3
SCHEMBL9314201 0.71 HDAC3 (0.53) AOC3TBXAS1MAPTHDAC3MAPK1
SCHEMBL7112651 0.70 CYP1A2 (0.42) TBXAS1MAPTHSD17B10
SCHEMBL23812457 0.70 AOC3 (0.67) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 — — EP disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 — — WO disclosed
Send feedback